{"id":"W2889330860","doi":"10.1136/annrheumdis-2018-eular.2347","title":"THU0313 Ixekizumab improves nail and skin lesions through 52 weeks in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Ixekizumab; Psoriasis; Adalimumab; Placebo; Secukinumab; Internal medicine; Population; Erythema; Etanercept; Gastroenterology; Tumor necrosis factor alpha; Dermatology; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004457388,0.0002695819,0.000864509,0.000151184,0.0001672942,0.0002948775,0.0001787305,0.0002580438,0.002111596],"category_scores_gemma":[0.0004329192,0.000151322,0.0005061354,0.0001353867,0.0001072916,0.0002545395,0.0001102646,0.0006688904,0.0002846894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002190578,"about_ca_system_score_gemma":0.0002428491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008075155,"about_ca_topic_score_gemma":0.00208157,"domain_scores_codex":[0.9998217,0.00005131339,0.00001692346,0.00002396847,0.00002956854,0.00005651702],"domain_scores_gemma":[0.9998206,0.00003437552,0.00005847165,0.00001211445,0.00002117899,0.00005318845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1264663,0.009900345,0.05404079,0.001246779,0.001882878,0.001003388,0.0002672382,0.001070102,0.07843454,0.0001734427,0.005938691,0.7195755],"study_design_scores_gemma":[0.04769837,0.1542288,0.7496296,0.0005146257,0.00318394,0.005078481,0.0005946216,0.004605262,0.01921627,0.0005097699,0.01465782,0.00008253728],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904468,0.006878725,0.0002718472,0.0003111573,0.00008728133,0.00005648822,0.0001246374,0.00006328095,0.001759831],"genre_scores_gemma":[0.9966144,0.001292116,0.0003208436,0.0002235716,0.00004006605,0.00002375778,0.0001318827,0.000006453329,0.001346848],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002111596,"threshold_uncertainty_score":0.007063925,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01611004636740815,"score_gpt":0.249292064786761,"score_spread":0.2331820184193529,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}